EUVIMEDEUVIMED entdecken
Crossref

Patient-Provider Discussion About Lung Cancer Screening by Race and Ethnicity: Implications for Equitable Uptake of Lung Cancer Screening

Young-Rock Hong, Meghann Wheeler, Ruixuan Wang, Shama Karanth, Hyung-Suk Yoon, Rafael Meza, Frederick Kaye, Jiang Bian, Jihyoun Jeon, Michael K Gould, Dejana Braithwaite

Clinical Lung Cancer · 2024

DOI: 10.1016/j.cllc.2023.08.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lung Cancer, 2024. Verfasst von Young-Rock Hong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Services Research, Management and Policy, College of Public Health and Health Professions, University of Florida, Gainesville, F…. Hauptthemen laut MEDLINE: Ethnicity, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Cancer Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Physician-patient discussions regarding lung cancer screening (LCS) are uncommon and its racial and ethnic disparities are under-investigated. We examined the racial and ethnic disparities in the trends and frequency of LCS discussion among the LCS-eligible United States (US) population. METHODS: We analyzed data from the Health Information National Trends Survey from 2014 to 2020. LCS-eligible individuals were defined as adults aged 55 to 80 years old who have a current or former smoking history. We estimated the trends and frequency of LCS discussions and adjusted the probability of having an LCS discussion by racial and ethnic groups. RESULTS: Among 2136 LCS-eligible participants (representing 22.7 million US adults), 12.9% (95% CI, 10.9%-15%) reported discussing LCS with their providers in the past year. The frequency of LCS discussion was lowest among non-Hispanic White participants (12.3%, 95% CI, 9.9%-14.7%) compared to other racial and ethnic groups (14.1% in Hispanic to 15.3% in non-Hispanic Black). A significant increase over time was only observed among non-Hispanic Black participants (10.1% in 2014 to 22.1% in 2020; P = .05) and non-Hispanic Whites (8.5% in 2014 to 14% in 2020; P = .02). In adjusted analyses, non-Hispanic Black participants (14.6%, 95% CI, 12.3%-16.7%) had a significantly higher probability of LCS discussion than non-Hispanic Whites (12.1%, 95% CI, 11.4%-12.7%). CONCLUSION: Patient-provider LCS discussion was uncommon in the LCS-eligible US population. Non-Hispanic Black individuals were more likely to have LCS discussions than other racial and ethnic groups. There is a need for more research to clarify the discordance between LCS discussions and the actual screening uptake in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EthnicityLung NeoplasmsAgedAged, 80 and overHumansMiddle AgedEarly Detection of CancerHispanic or LatinoUnited StatesBlack or African American

Stichwörter der Autor:innen

Early detection of cancerHealth disparateLung neoplasmsMinority and vulnerable populationsShared decision making

Autor:innen und Institutionen

  • Department of Health Services Research, Management and Policy, College of Public Health and Health Professions, University of Florida, Gainesville, FL; UF Health Cancer Center, Gainesville, FL. Electronic address: young…
  • Department of Epidemiology, College of Public Health and Health Professions, University of Florida, Gainesville, FL.
  • Department of Health Services Research, Management and Policy, College of Public Health and Health Professions, University of Florida, Gainesville, FL.
  • UF Health Cancer Center, Gainesville, FL; Department of Surgery, College of Medicine, University of Florida, Gainesville, FL.
  • Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada; Department of Epidemiology, University of Michigan, Ann Arbor, MI.
  • Division of Hematology & Oncology, College of Medicine, University of Florida, Gainesville, FL.

Förderung

  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Hong, Y. R., Wheeler, M., Wang, R., Karanth, S., Yoon, H. S., Meza, R., Kaye, F., Bian, J., Jeon, J., Gould, M. K., & Braithwaite, D. (2024). Patient-Provider Discussion About Lung Cancer Screening by Race and Ethnicity: Implications for Equitable Uptake of Lung Cancer Screening. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2023.08.013

Vancouver

Hong YR, Wheeler M, Wang R, Karanth S, Yoon HS, Meza R, et al. Patient-Provider Discussion About Lung Cancer Screening by Race and Ethnicity: Implications for Equitable Uptake of Lung Cancer Screening. Clinical Lung Cancer. 2024. doi:10.1016/j.cllc.2023.08.013

BibTeX
@article{Hong2024,
  author = {Hong, Young-Rock and Wheeler, Meghann and Wang, Ruixuan and Karanth, Shama and Yoon, Hyung-Suk and Meza, Rafael and Kaye, Frederick and Bian, Jiang and Jeon, Jihyoun and Gould, Michael K and Braithwaite, Dejana},
  title = {Patient-Provider Discussion About Lung Cancer Screening by Race and Ethnicity: Implications for Equitable Uptake of Lung Cancer Screening},
  journal = {Clinical Lung Cancer},
  year = {2024},
  doi = {10.1016/j.cllc.2023.08.013}
}
Kostenlos starten →